The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,499
Sort by:
Adenosine Receptor A1 (ADORA1) - Drugs in Development, 2021
US$ 3,000.00
Adenosine Receptor A1 (ADORA1) - Drugs in Development, 2021 SUMMARY Adenosine Receptor A1 (ADORA1) - Drugs in Development, 2021 provides in depth analysis on Adenosine Receptor A1 (ADORA1) targeted pi...
April 2021
45 pages
Ageing (Other Diseases) - Drugs in Development, 2021
US$ 2,000.00
Ageing (Other Diseases) - Drugs in Development, 2021 SUMMARY Ageing (Other Diseases) - Drugs in Development, 2021 provides an overview of the Ageing pipeline landscape. The report provides comprehensi...
April 2021
105 pages
Allergic Asthma (Respiratory) - Drugs in Development, 2021
US$ 2,000.00
Allergic Asthma (Respiratory) - Drugs in Development, 2021 SUMMARY Allergic Asthma (Respiratory) - Drugs in Development, 2021 provides an overview of the Allergic Asthma pipeline landscape. The report...
April 2021
115 pages
Alopecia Areata (Dermatology) - Drugs in Development, 2021
US$ 2,000.00
Alopecia Areata (Dermatology) - Drugs in Development, 2021 SUMMARY Alopecia Areata (Dermatology) - Drugs in Development, 2021 provides an overview of the Alopecia Areata pipeline landscape. The report...
April 2021
60 pages
Angiosarcoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Angiosarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Angiosarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Angiosarcoma pipeline landscape. The report provides compr...
April 2021
50 pages
